Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Yahoo/BusinessWire
Friday, May 24, 2013 - 10:37am
tags:
Astellas, Medivation, Enzalutamide, prostate
Arena - Good Sales, Bad Sales, Long And Short
Seeking Alpha
Friday, May 24, 2013 - 10:34am
tags:
Arena Pharmaceutical
3 Pipeline Obesity Treatments You Should Watch
Motley Fool
Thursday, May 23, 2013 - 12:03pm
tags:
obesity, Vivus, Orexigen, Contrave, Belviq, tesofensine, Neurosearch, Qsymia, Arena Pharmaceuticals
Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability
Seeking Alpha
Thursday, May 23, 2013 - 11:57am
tags:
Belviq, obesity, Arena Pharmaceuticals, off-label
Royalty Pharma eases condition for Elan offer
Yahoo/AP
Thursday, May 23, 2013 - 11:53am
tags:
Royalty Pharma, Elan, M&A
Ranbaxy said to be eyeing major cuts to sales force, mainly in U.S.
Fierce Pharma
Thursday, May 23, 2013 - 11:52am
tags:
Ranbaxy, layoffs
BioMarin Gains on Prospects for Experimental Cancer Drug
Bloomberg
Thursday, May 23, 2013 - 11:49am
tags:
Biomarin, Ewing's sarcoma, BMN-673, breast cancer, ovarian cancer, small cell lung cancer
Boston Scientific Entangled in Patent Issues
Yahoo/Zacks
Thursday, May 23, 2013 - 11:43am
tags:
Boston Scientific, patents, OrbusNeich Medical, devices, stents
Merck, Lilly, Pfizer share top billing in $1B doc-payments list
Fierce Pharma
Thursday, May 23, 2013 - 11:36am
tags:
Merck, Eli Lilly, Pfizer, physician payments
Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha
Thursday, May 23, 2013 - 11:32am
tags:
Optina, Regeneron, Novartis, Eylea, Ampio Pharmaceuticals, age-related macular degeneration, Lucentis
Novartis Acknowledges Employees Participated In 'Independent' Trials
Forbes
Thursday, May 23, 2013 - 11:29am
tags:
Novartis, clinical trials, Diovan
Forest CEO Solomon Finally Listens To Carl Icahn And Will Retire
Pharmalot
Thursday, May 23, 2013 - 11:01am
tags:
Pharma CEOs, Carl Icahn, Forest Labs, Howard Solomon
GSK flu shot may raise adult narcolepsy risk: Finnish scientists
Yahoo/Reuters
Thursday, May 23, 2013 - 10:58am
tags:
H1N1, vaccines, narcolepsy, GSK, Pandemrix
Steve Nissen: The FDA Meeting On Avandia Will Be A 'Whitewash'
Pharmalot
Thursday, May 23, 2013 - 10:51am
tags:
FDA, Avandia, Steve Nissen, GSK, diabetes
Will Ranbaxy Labs Be Excluded From Medicare And Medicaid?
Forbes
Thursday, May 23, 2013 - 10:47am
tags:
Ranbaxy, Medicare, Medicaid
J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizer
Forbes
Thursday, May 23, 2013 - 10:44am
tags:
JNJ, Medivation, Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, Xarelto, Zytiga
AbbVie Price Boost of Drug Slammed in Studies Criticized
Bloomberg
Thursday, May 23, 2013 - 10:43am
tags:
drug pricing, AbbVie, Niaspan
MannKind's Afrezza And The Oramed Threat
Seeking Alpha
Thursday, May 23, 2013 - 10:29am
tags:
MannKind, Afrezza, diabetes, Oramed Pharmaceuticals, ORMD-0801
[video]Merck's Magic Sleeping Pills Wake Up Big Pharma
Bloomberg
Thursday, May 23, 2013 - 10:25am
tags:
insomnia, Merck, suvorexant
Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
Yahoo
Thursday, May 23, 2013 - 10:01am
tags:
Lpath, Asonep, renal cell carcinoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.